Mutual recognition in the European system: A blueprint for increasing access to medicines?

The European regulatory system for approval of medicinal products is globally recognised as a unique platform for regulatory work-sharing and mutual recognition. As such, it potentially serves as a role model for regulatory capacity building worldwide. While focusing on mutual recognition and decentralised procedures, this paper illustrates key success factors and structures allowing for the reliance-based authorisation of medicines in the European Economic Area from the perspective of a national regulatory authority (NRA).

Patients in cardiac rehabilitation programme--where we were in 1999 and where 10 years later.

The aim of this study was to find out and compare characteristics of cardiac patients who, after hospital treatment, participated in cardiac rehabilitation programmes at the Polyclinic for Cardiovascular Prevention and Rehabilitation in Zagreb during 1999 and 2009. The results show an increase in mean patients' age (men: 55.5 to 61.

[Roentgenologic characteristics of bronchopulmonary carcinoma].

The roentgenologic characteristics of bronchopulmonary carcinoma were studied in 578 patients in whom the disease had been diagnosed by bronchoscopy and confirmed by cytopathologic finding. Each of the pulmonary disease may imitate bronchopulmonary carcinoma and vice versa. Since there is no roentgenologic patognomonic sign for bronchopulmonary carcinoma the sorts and distribution of characteristic X-ray signs were examined.

[The role of fiberoptic bronchoscopy in the detection of bronchopulmonary carcinoma].

The results of 578 bronchoscopy findings are presented in two periods of time differing in the method of performing the bronchologic procedure. The first period refers to the time from 1977-1979 when the rigid bronchoscope was applied while the second period was from 1980-1982 when the routine method of fiberbronchoscopy was introduced. During 1977-1979 78.